New York State Common Retirement Fund’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $275K | Buy |
7,036
+1,500
| +27% | +$46.3K | ﹤0.01% | 2242 |
|
|
2026
Q1 | $150K | Hold |
5,536
| – | – | ﹤0.01% | 2348 |
|
|
2025
Q4 | $237K | Hold |
5,536
| – | – | ﹤0.01% | 2219 |
|
|
2025
Q3 | $157K | Hold |
5,536
| – | – | ﹤0.01% | 2407 |
|
|
2025
Q2 | $104K | Hold |
5,536
| – | – | ﹤0.01% | 2591 |
|
|
2025
Q1 | $99.6K | Buy |
5,536
+2,200
| +66% | +$44.6K | ﹤0.01% | 2515 |
|
|
2024
Q4 | $56.1K | Hold |
3,336
| – | – | ﹤0.01% | 2825 |
|
|
2024
Q3 | $54K | Sell |
3,336
-1
| -0% | -$12 | ﹤0.01% | 2838 |
|
|
2024
Q2 | $27.4K | Buy |
3,337
+17
| +0.5% | +$178 | ﹤0.01% | 3187 |
|
|
2024
Q1 | $49.1K | Sell |
3,320
-24
| -0.7% | -$323 | ﹤0.01% | 2988 |
|
|
2023
Q4 | $48.5K | Sell |
3,344
-29
| -0.9% | -$297 | ﹤0.01% | 3004 |
|
|
2023
Q3 | $36.4K | Buy |
3,373
+54
| +2% | +$650 | ﹤0.01% | 3097 |
|
|
2023
Q2 | $42.8K | Sell |
3,319
-25
| -0.7% | -$338 | ﹤0.01% | 3157 |
|
|
2023
Q1 | $44.1K | Sell |
3,344
-6,810
| -67% | -$108K | ﹤0.01% | 3010 |
|
|
2022
Q4 | $152K | Buy |
10,154
+8
| +0.1% | +$73 | ﹤0.01% | 2839 |
|
|
2022
Q3 | $120K | Buy |
10,146
+26
| +0.3% | +$352 | ﹤0.01% | 2962 |
|
|
2022
Q2 | $114K | Sell |
10,120
-33
| -0.3% | -$663 | ﹤0.01% | 3020 |
|
|
2022
Q1 | $304K | Buy |
10,153
+8
| +0.1% | +$217 | ﹤0.01% | 2643 |
|
|
2021
Q4 | $269K | Sell |
10,145
-34
| -0.3% | -$1.03K | ﹤0.01% | 2761 |
|
|
2021
Q3 | $369K | Sell |
10,179
-2,575
| -20% | -$101K | ﹤0.01% | 2630 |
|
|
2021
Q2 | $554K | Sell |
12,754
-2,186
| -15% | -$82.5K | ﹤0.01% | 2541 |
|
|
2021
Q1 | $511K | Hold |
14,940
| – | – | ﹤0.01% | 2447 |
|
|
2020
Q4 | $523K | Hold |
14,940
| – | – | ﹤0.01% | 2328 |
|
|
2020
Q3 | $359K | Hold |
14,940
| – | – | ﹤0.01% | 2373 |
|
|
2020
Q2 | $273K | Hold |
14,940
| – | – | ﹤0.01% | 2508 |
|
|
2020
Q1 | $233K | Hold |
14,940
| – | – | ﹤0.01% | 2390 |
|
|
2019
Q4 | $320K | Hold |
14,940
| – | – | ﹤0.01% | 2514 |
|
|
2019
Q3 | $279K | Hold |
14,940
| – | – | ﹤0.01% | 2609 |
|
|
2019
Q2 | $390K | Hold |
14,940
| – | – | ﹤0.01% | 2495 |
|
|
2019
Q1 | $384K | Hold |
14,940
| – | – | ﹤0.01% | 2425 |
|
|
2018
Q4 | $344K | Sell |
14,940
-150
| -1% | -$4.23K | ﹤0.01% | 2457 |
|
|
2018
Q3 | $484K | Hold |
15,090
| – | – | ﹤0.01% | 2421 |
|
|
2018
Q2 | $427K | Buy |
15,090
+390
| +3% | +$13.9K | ﹤0.01% | 2515 |
|
|
2018
Q1 | $520K | Buy |
14,700
+3,160
| +27% | +$126K | ﹤0.01% | 2337 |
|
|
2017
Q4 | $448K | Hold |
11,540
| – | – | ﹤0.01% | 2407 |
|
|
2017
Q3 | $293K | Hold |
11,540
| – | – | ﹤0.01% | 2609 |
|
|
2017
Q2 | $315K | Sell |
11,540
-2,900
| -20% | -$79.4K | ﹤0.01% | 2642 |
|
|
2017
Q1 | $478K | Buy |
14,440
+3,490
| +32% | +$88.9K | ﹤0.01% | 2402 |
|
|
2016
Q4 | $261K | Hold |
10,950
| – | – | ﹤0.01% | 2673 |
|
|
2016
Q3 | $402K | Hold |
10,950
| – | – | ﹤0.01% | 2424 |
|
|
2016
Q2 | $244K | Hold |
10,950
| – | – | ﹤0.01% | 2634 |
|
|
2016
Q1 | $228K | Hold |
10,950
| – | – | ﹤0.01% | 2621 |
|
|
2015
Q4 | $332K | Hold |
10,950
| – | – | ﹤0.01% | 2502 |
|
|
2015
Q3 | $270K | Sell |
10,950
-1,159
| -10% | -$34.6K | ﹤0.01% | 2622 |
|
|
2015
Q2 | $389K | Buy |
12,109
+9,209
| +318% | +$352K | ﹤0.01% | 2633 |
|
|
2015
Q1 | $104K | Buy |
+2,900
| New | +$79.5K | ﹤0.01% | 2218 |
|
Other funds holding RIGL
HWAM
BC
New York State Common Retirement Fund's RIGL Position: Q2 2026 in Review
New York State Common Retirement Fund increased its Rigel Pharmaceuticals (RIGL) stake by 27% in Q2 2026, buying an estimated $46.3K and bringing the position to 7,036 shares worth $275K. The position accounts for ﹤0.01% of the portfolio, ranked #2242.
New York State Common Retirement Fund first reported a position in RIGL in Q1 2015 and has held it in 46 quarters since. The position peaked at $554K in Q2 2021. 45 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.
- New York State Common Retirement Fund held 7,036 shares of Rigel Pharmaceuticals worth $275K as of Q2 2026.
- New York State Common Retirement Fund bought 1,500 Rigel Pharmaceuticals shares in Q2 2026, an estimated $46.3K.
- Rigel Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2242 holding.
- New York State Common Retirement Fund first reported a position in Rigel Pharmaceuticals in Q1 2015 and has held it in 46 quarters since.
- New York State Common Retirement Fund's Rigel Pharmaceuticals position peaked at $554K in Q2 2021.
- 45 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.
Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.